Literature DB >> 15205666

Increasing T-cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model.

Jeff S Friedman1, Onder Alpdogan, Marcel R m van den Brink, Chen Liu, Daniel Hurwitz, Ashleigh Boyd, Thomas S Kupper, Steven J Burakoff.   

Abstract

Aging of T cells is characterized by a series of alterations in surface antigen expression and a concomitant decline in functional activity in many assays. We have extended this analysis by comparing the ability of T cells from mice of different ages to cause graft-versus-host disease (GVHD) by using a parent into F(1) model (C57BL/6 T cells into C57BL/6 x C3H host animals). Young (3-5 months), adult (12-14 months), or old (19-24 months) T cells were introduced into irradiated F(1) hosts. Animals that had undergone transplantation were assessed for clinical and pathologic evidence of GVHD and for survival. At a given T-cell dose (2 x 10(6) cells), there was a T-cell (donor) age-dependent decline in severity of GVHD, with all recipients of young T cells succumbing to lethal GVHD, 75% of recipients of adult T cells succumbing, and no deaths occurring among recipients of old T cells. In vivo CD4 T-cell expansion was greater for young than old T-cell groups after transplantation, whereas old CD8 cells showed enhanced in vivo expansion compared with young cells. Among CD4 and CD8 cells, the T-cell receptor repertoire, surface antigen expression on activated cells, and homing receptor function were similar for all ages after expansion in vivo. The progeny of old T cells reisolated after transplantation expressed type 1 cytokines (interferon-gamma and tumor necrosis factor-alpha) at a lower frequency than young cells and had decreased cytolytic function against H-2(k)-bearing target cells. This provides a partial explanation for the decreased GVHD. Carboxyfluorescein diacetate succinimidyl ester labeling of transplanted cells showed comparable rates of proliferation when comparing GVHD-competent (12 months) and GVHD-incompetent (19 months) T cells in both syngeneic and F(1) host animals. We suggest that the lack of effector activity demonstrated by old T cells in vivo is a reflection of a cell-autonomous defect downstream of signals required for antigen-driven proliferation.

Entities:  

Mesh:

Year:  2004        PMID: 15205666     DOI: 10.1016/j.bbmt.2004.03.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  5 in total

1.  In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.

Authors:  Andreas Beilhack; Stephan Schulz; Jeanette Baker; Georg F Beilhack; Courtney B Wieland; Edward I Herman; Enosh M Baker; Yu-An Cao; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2005-04-26       Impact factor: 22.113

2.  In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?

Authors:  R Peffault de Latour; M Labopin; J Cornelissen; S Vigouroux; C Craddock; D Blaise; A Huyn; L Vindelov; J Maertens; P Chevallier; N Fegueux; G Socié; J Y Cahn; E Petersen; H Schouten; B Lioure; N Russell; L L Corral; F Ciceri; A Nagler; M Mohty
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

3.  Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

Authors:  Amin M Alousi; Jennifer Le-Rademacher; Rima M Saliba; Frederick R Appelbaum; Andrew Artz; Jonathan Benjamin; Steven M Devine; Fangyu Kan; Mary J Laughlin; Hillard M Lazarus; Jane Liesveld; Miguel-Angel Perales; Richard T Maziarz; Mitchell Sabloff; Edmund K Waller; Mary Eapen; Richard E Champlin
Journal:  Blood       Date:  2013-01-29       Impact factor: 22.113

4.  Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors.

Authors:  Sophie Servais; Raphaël Porcher; Alienor Xhaard; Marie Robin; Emeline Masson; Jerome Larghero; Patricia Ribaud; Nathalie Dhedin; Sarah Abbes; Flore Sicre; Gérard Socié; Regis Peffault de Latour
Journal:  Haematologica       Date:  2013-11-15       Impact factor: 9.941

Review 5.  Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia.

Authors:  Jodi J Lipof; Kah Poh Loh; Kristen O'Dwyer; Jane L Liesveld
Journal:  Cancers (Basel)       Date:  2018-06-04       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.